Prevalence and clinical characterization of cancer patients with asymptomatic SARS-CoV-2 infection history
- PMID: 32711041
- PMCID: PMC7375288
- DOI: 10.1016/j.jinf.2020.07.018
Prevalence and clinical characterization of cancer patients with asymptomatic SARS-CoV-2 infection history
Abstract
- •
We retrospectively studied the prevalence and clinical characterization of cancer patients with asymptomatic SARS-CoV-2 infection history in the only cancer hospital in Wuhan.
- •
Serosurvey of SARS-CoV-2 among hospital visitors from two hospitals, one at the epicenter in Wuhan, and one outside the epicenter, in Guangzhou.
- •
Cancer patients are more likely to develop asymptomatic COVID-19 infection than persons with similar exposure history.
- •
Transmissibility of asymptomatic cases is relatively low, even in vulnerable populations such as cancer patients.
Conflict of interest statement
Declaration of Competing Interest All other authors declare no competing interests.
Figures
Comment on
-
How is immunosuppressive status affecting children and adults in SARS-CoV-2 infection? A systematic review.J Infect. 2020 Jul;81(1):e61-e66. doi: 10.1016/j.jinf.2020.04.026. Epub 2020 Apr 23. J Infect. 2020. PMID: 32335173 Free PMC article.
References
-
- Liang W., Guan W., Chen R. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020 doi: 10.1016/S1470-2045(20)30096-6. published online Feb 14http://dx.doi.org/ - DOI - PMC - PubMed
-
- National Health Commission of China. New coronavirus pneumonia prevention and control program (7th edn). Mar 3, 2020. http://www.gov.cn/zhengce/zhengceku/2020-03/04/5486705/files/ae61004f930...(in Chinese).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous